Shares of Synthomer plc (LON:SYNT – Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 243.55 ($3.07) and traded as low as GBX 170 ($2.14). Synthomer shares last traded at GBX 174 ($2.19), with a volume of 241,692 shares.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on SYNT shares. Canaccord Genuity Group reduced their price objective on shares of Synthomer from GBX 300 ($3.78) to GBX 275 ($3.47) and set a “buy” rating on the stock in a research report on Friday, October 4th. Berenberg Bank reduced their price target on shares of Synthomer from GBX 375 ($4.73) to GBX 340 ($4.28) and set a “buy” rating on the stock in a report on Tuesday, August 13th.
Check Out Our Latest Stock Report on Synthomer
Synthomer Price Performance
About Synthomer
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Featured Stories
- Five stocks we like better than Synthomer
- Top Stocks Investing in 5G Technology
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Industrial Products Stocks Investing
- Top-Performing Non-Leveraged ETFs This Year
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.